Search results
US approves Moderna's RSV vaccine for older adults
Alaska Superstation· 4 days agoThe US Food and Drug Administration on Friday approved Moderna's respiratory syncytial virus (RSV) vaccine for older adults -- marking the first time any...
The Moderna Selloff Gains Steam. An Analyst Has a Few Theories Why.
Barrons.com· 6 days agoThe stock was down 5.5% Wednesday morning, bringing the stocks losses to 13% since the market closed...
Moderna secures a second FDA vaccine approval as Spikevax sales plummet
Fast Company Magazine· 4 days agoThis will be the only RSV vaccine available in single-dose prefilled syringes and will be sold under...
Insider Selling: Moderna, Inc. (NASDAQ:MRNA) Insider Sells 1,296 Shares of Stock
ETF DAILY NEWS· 5 days agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) insider Shannon Thyme Klinger sold 1,296 shares of the company’s stock in a transaction dated Tuesday, May 28th. Following the ...
Moderna wins second product approval with RSV vaccine
Market Watch· 4 days agoModerna Inc.’s respiratory syncytial virus vaccine for older adults received U.S. regulatory...
Moderna director Noubar Afeyan sells shares worth over $2.9 million By Investing.com
Investing.com· 4 days agoModerna , Inc. (NASDAQ:MRNA) director Noubar Afeyan has sold a total of $2,901,584 worth of company...
FDA approves Moderna’s mRNA RSV vaccine for older adults
KOMU Columbia· 3 days agoThe shot, made by Moderna and sold under the name of mResvia, could be another tool in the country’s...
Moderna nears deal with US government to receive funding for bird flu vaccine, report says - The...
The Boston Globe· 5 days agoThe Cambridge-based biotechnology company declined to share specifics but confirmed to the Globe...
Scientists are testing vaccines to protect cows and people against bird flu
Temple Daily Telegram· 12 hours agoThe bird flu outbreak in U.S. dairy cows is prompting development of new, next-generation mRNA ...
Why Moderna Stock Is Sinking This Week | The Motley Fool
The Motley Fool· 5 days agoThe decline appears to be the result of investors taking profits after Moderna stock soared 25% last...